4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099128
SVP, Head of Finance & Admin. sold 2,752 shares at an average $45.12 ($124,174)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Scalzo Richard William · SVP, Head of Finance & Admin.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-19 | Sale : show line 1 in the form 10b5-1 | −2,442 | $45.01 | $109,914 | 111,332 | D |
| 2024-08-19 | Sale : show line 2 in the form 10b5-1 | −310 | $46.00 | $14,260 | 111,022 | D |
| Open-market sales · 2,752 sh · avg $45.12 · $124,174 | ||||||
Loading xslF345X05/ownership.xml…